Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)

Completed

Conditions studied: Prostatic Neoplasms

In brief

This retrospective observational multi centered study has been established to collect the clinical experience relating to the administration of Fluciclovine 18F employed in both investigator initiated studies and named patient/compassionate use programmes in up to 5 sites.

Key facts

Study ID

NCT02443571

Run by

Blue Earth Diagnostics

People needed

714

Starts

2015-01-01

Expected to finish

2015-06-01

Last updated by the study team

2018-12-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient managed by a site at which ethical committee approval for retrospective data collection under this protocol has been received
• Patient has received at least one injection of fluciclovine (18F) for the detection of a malignant tumour at any location

You may not qualify if…

• Subjects will be excluded from the analyses if any of the following criteria are met:
• Patients participating in clinical trials or open access programmes at countries or sites not participating in this study.
• Patients managed at sites without ethical committee approval for retrospective data collection under this protocol.

Where it is running

• Emory University Hospital — Atlanta, Georgia, United States
• University Hospital Sant'Orsola Malpighi — Bologna, Italy
• Oslo University Hospital — Oslo, Norway
• Aleris Kreftsenter — Oslo, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.